Vitamin D and Calcium Supplementation in Breast Cancer

• Status: Not yet recruiting
• Trial end date: 2023-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study aims at assessing the vitamin Dstatus in breast cancer patients who receive letrozole for more than two months and to evaluate effects of vitamin D3 and calcium supplementation on arthalgia caused by letrozole on these patients.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Vitamin D

Criteria

Inclusion Criteria:

• Newly diagnosed breast cancer patients.

• Postmenopausal hormone receptor positive.

• Patients receiving letrozole for more than two months

• Gender: Female.

• Age: ≥ 50 years old.

Exclusion Criteria:

• Patients with bone metastasis.

• History of renal stones.

• Serum calcium >11mg/L.

• Patients with renal insufficiency.

• Patients taking steroid hormone replacement therapy.

• Second Malignancy.